2020/4/3  
英文 English 
People in 20s have Taiwan’s highest infection rate: COVID-19 case data (2020/03/26)

More than 30% of Taiwan's COVID-19 cases are people in their 20s, according to a breakdown of case data released for the first time. Officials published this analysis of Taiwan's COVID-19 outbreak on Thursday, providing statistics that could help shape policy. Unlike in other countries, more women than men in Taiwan have caught the disease. Meanwhile, trials of potential treatments are showing promising results. Health officials said that the use of hydroxychloroquine was found effective for mild cases during small and preliminary trials.

Chang Shan-chwen
Central Epidemic Command Center specialist
So far, we’ve tested almost 30,000 people and more than 230 have been confirmed positive.

The first statistics about Taiwan’s COVID-19 cases have been unveiled. More women caught the virus than men. The largest age demographic is those in their 20s. The country that’s exported the most cases to Taiwan seems to be the U.S. More than 70% of cases present with just mild symptoms, but only 28 people have recovered and left the hospital after a serious case. A full recovery has taken as long as 53 days. Officials also revealed new details on drug trials.

Chang Shan-chwen
Central Epidemic Command Center specialist
We have started clinical trials of remdesivir. It is being tested in three hospitals in the north, center and south of the country. Resident physicians describe it as working quite well.

Three patients are being treated with remdesivir. Their fevers have reduced, and doctors are continuing to monitor how their recovery progresses. The anti-malaria drug hydroxychloroquine has also been tipped as a potential COVID-19 drug in official guidelines.

Chang Shan-chwen
Central Epidemic Command Center specialist
It can be used also for mild cases or before symptoms present. It is probably not suitable for pregnant women. Long-term use could lead to damage to the retina. Short-term use can also affect the heart and heart rate negatively.

Chen Shih-chung
Central Epidemic Command Center
Many firms can make it but there’s one main manufacturer. This manufacturer has a strong sense of social responsibility. They’ve promised to guarantee Taiwan’s supply first. The government is going to protect their profits and help with the distribution, to make this international cooperation as smooth as possible.

Health minister Chen Shih-chung said Taiwan’s hydroxychloroquine production can easily meet domestic demand. Local producers are in talks with 20 countries that wish to buy the drug, but there’ll be some delay before supply is ready.

中文 Chinese  
台灣3人接受瑞德西韋投藥奎寧用於輕度

疫情指揮中心今天首度公布確診完整案例分析,女性多於男性,占57%;年齡20至29多達84例,占三成多最高。在美國被感染者最多,有41位。治療藥物也公開,常用在風濕免疫科的「奎寧」,正式納入治療指引,陳時中掛保證,供貨無虞。但張上淳也驚訝,說這個病毒很不尋常,病患體內有抗體,呼吸道卻仍驗到病毒。

[[疫情指揮中心專家諮詢小組召集人 張上淳]]
“到現在為止我們通通的篩檢,將近3萬例的個案,總共確診是230幾例。”


疫情指揮中心首次分析台灣確診案例,包含:女性多於男性;20到29歲年輕人最多;境外移入被感染國家,以美國佔最大宗。雖然超過7成為輕症,但至今出院只有28例,甚至有人要53天才痊癒,治療藥物,也公開。

[[疫情指揮中心專家諮詢小組召集人 張上淳]]
“瑞德西韋藥物,現在我們是正式進入到,臨床實驗當中,那台灣在北中南都有一家醫院,根據主治醫師的描述是覺得(效果)蠻不錯的。”

三位病人接受「瑞德西韋」投藥,用藥後有退燒,並持續觀測排毒情況。另一種,風濕免疫科常用的「奎寧」,也正式納入武肺治療指引。

[[疫情指揮中心專家諮詢小組召集人 張上淳]]
“不管是輕症、還沒有肺炎等等都可以拿來用,那懷孕婦女大概就不太能用,此外這個,當然長期使用,有可能有視網膜病變的問題,短期的使用也可能有,對心臟、心律的一些影響。”

[[疫情指揮中心指揮官 陳時中]]
“很多家可以做,不過最主要的生產商有一家,那這家生產商也很有社會責任,他已經先台灣的需要量,都一定會先保留。政府在保障他的利益之下,參與這樣的分配,能夠讓國際合作能夠過得更順暢。”

陳時中掛保證,台灣有奎寧原藥廠,貨源超充足,已經有20國接洽,但想買貨,得再等等。

關於民視 常見問題 如何收看民視 意見信箱

© 2009 FTV All Rights Reserved 版權所有‧盜用必究 Designed by FTV
地址:244 新北市林口區信義路99號   觀服電話:(02)8601-8601 服務時間:週一至週日09:00-21:00   傳真:(02)8601-3955

本網站使用 cookie 與其他技術為您提供更好的使用體驗, 請閱讀我們的的隱私權政策,通過使用我們的網站,表示您確認並同意我們的政策。